Is Astrana Health, Inc. a good investment? Astrana Health, Inc. (ASTH) is currently trading at 35.91 USD. Market analysts have a consensus price target of 49.33 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 58.30. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Astrana Health, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 3.42.
No, it does not currently pay a dividend.
Astrana Health, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.61.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 26, 2007 | 0.010000 |
| April 27, 2015 | 0.100000 |
Community Discussion